ENDOMETRIAL NEOPLASIA WITH ADJUVANT TAMOXIFEN TREATMENT IN BREAST CANCER PATIENTS : REPORT OF NON-ENDOMETRIOID SUBTYPES

Volume: 44 Number: 2 June 1, 2005
  • Yıldız Erhan
  • Osman Zekioğlu
  • Mustafa COŞAN Terek
  • Levent Akman
  • Aydın Özsaran
  • Yılmaz Dikmen
  • Fatih Şendağ
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

ENDOMETRIAL NEOPLASIA WITH ADJUVANT TAMOXIFEN TREATMENT IN BREAST CANCER PATIENTS : REPORT OF NON-ENDOMETRIOID SUBTYPES

Abstract

The aim of the present study is to report the clinicopathologic features of endometrial cancers subsequently develepod after adjuvant treatment of breast cancer with tamoxifen. Seven endometrial cancers in tamoxifen-treated breast cancer patients were treated at our institution between 1994 and 2002. Medical reports of the patients were evaluated retrospectively. All patients were postmenopausal and one patient was nulliparous. The age at discovery of the endometrial carcinoma ranged from 53-78. The menopausal age ranged from 40-53. Six of seven postmenopausal patients had postmenopausal uterine bleeding as the initial complaint. Only one patient was found to have endometrial cancer at annual gynecologic examination. Endometrial neoplasia was diagnosed by dilatation and curettage in all cases. The patients had been treated with 20 mg of tamoxifen daily for 1-14 years. Six patients were found to have endometrial carcinoma during adjuvant tamoxifen treatment. Only one patient developed endometrial carcinoma six years after the cessation of adjuvant tamoxifen treatment. Histopathologic examination of the specimens revelaed five cases of adenocarcinoma and two cases of sarcoma. Malignant mixed mesodermal tumor and adenosarcoma of the endometrium developed in long-term tamoxifen users (8 and 14 years, respectively). Patients with breast cancer using adjuvant tamoxifen treatment, especially the long-term users should be monitored for the possibility of endometrial neoplasia. It is notable that five out of seven endometrial malignancies were not of endometrioid subtype.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Yıldız Erhan

Osman Zekioğlu

Mustafa COŞAN Terek

Levent Akman

Aydın Özsaran

Yılmaz Dikmen

Fatih Şendağ

Publication Date

June 1, 2005

Submission Date

June 1, 2005

Acceptance Date

-

Published in Issue

Year 1970 Volume: 44 Number: 2

IZ

https://izlik.org/JA77KL25GS

Cite

RIS / Bibtex
Vancouver
1.Yıldız Erhan, Osman Zekioğlu, Mustafa COŞAN Terek, Levent Akman, Aydın Özsaran, Yılmaz Dikmen, Fatih Şendağ. ADJUVAN TAMOKSİFEN TEDAVİSİ ALAN MEME KANSERLİ HASTALARDA ENDOMETRİAL NEOPLAZİ : NON-ENDOMETRİOİD ALT GRUPLARININ SUNUMU. EJM [Internet]. 2005 Jun. 1;44(2):101-5. Available from: https://izlik.org/JA77KL25GS

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.